oleanolic acid has been researched along with s 0139 in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (61.90) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haque, MS; Kitazawa, Y; Okada, K; Sugiyama, K; Taniguchi, T | 1 |
| Haque, SR; Hayakawa, T; Kitazawa, Y; Okada, K; Sugiyama, K; Taniguchi, T | 1 |
| Fujimoto, M; Kohnoike, T; Matumura, S; Mihara, S; Nakajima, S | 1 |
| Davenport, AP; Russell, FD | 1 |
| Haque, MS; Kitazawa, Y; Nakai, Y; Okada, K; Sugiyama, K; Taniguchi, T | 2 |
| Masuda, K; Oshika, T; Shoji, N | 1 |
| Fujimoto, M; Itazaki, K; Mihara, S; Tozawa, F | 1 |
| Fujimoto, M; Hiramatsu, K; Kita, T; Kubo, K; Nakashima, T; Sakaki, T; Sato, S; Yonetani, Y | 1 |
| Amano, S; Masuda, K; Oshika, T; Shoji, N | 1 |
| Fujimoto, M; Hata, S; Kuroda, T; Mihara, S; Shimizu, T | 1 |
| Fujita, K; Ishikawa, A; Suzuki, K | 1 |
| Kita, T; Kubo, K; Momochi, C; Nakashima, T; Narushima, I; Shimada, K; Yonetani, Y; Yoshikawa, I | 1 |
| Arai, M; Kanda, T; Kobayashi, I; Kurabayashi, M; Nagai, R; Sekiguchi, K; Seta, Y; Tanaka, T; Yokoyama, T | 1 |
| Hayasaki-Kajiwara, Y; Iwasaki, T; Nakajima, M; Naya, N; Shimamura, T | 1 |
| Inagaki, K; Kihara, Y; Sasayama, S; Takeuchi, Y; Yoneda, T | 1 |
| Fujimoto, M; Matsuo, Y; Ninomiya, M | 1 |
| Wu-Wong, JR | 1 |
| Albala, B; Chopp, M; Cui, Y; Kapke, A; Lu, M; Nagafuji, T; Ninomiya, M; Roberts, C; Zhang, C; Zhang, L; Zhang, RL; Zhang, ZG | 1 |
| Ritter, JM | 1 |
| Albala, B; Francis-Lang, A; Laurijssens, BE; Lunnon, MW; Maltby, K; Mistry, P; Nagafuji, T; Palmer, JE; Wallace, SM; Wilkinson, IB | 1 |
1 review(s) available for oleanolic acid and s 0139
| Article | Year |
|---|---|
S-0139 (Shionogi).
Topics: Animals; Caffeic Acids; Clinical Trials as Topic; Drug Industry; Endothelin Receptor Antagonists; Humans; Oleanolic Acid; Receptor, Endothelin A; Stroke | 2002 |
20 other study(ies) available for oleanolic acid and s 0139
| Article | Year |
|---|---|
Intraocular pressure response to intravitreal injection of endothelin-1 and the mediatory role of ETA receptor, ETB receptor, and cyclooxygenase products in rabbits.
Topics: Animals; Aqueous Humor; Caffeic Acids; Dinoprostone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Female; Indomethacin; Injections; Intraocular Pressure; Male; Oleanolic Acid; Prostaglandin-Endoperoxide Synthases; Rabbits; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Vasoconstrictor Agents; Viper Venoms; Vitreous Body | 1995 |
[The effect of an endothelin receptor antagonist, 97-139, on intraocular pressure in rabbits].
Topics: Animals; Aqueous Humor; Caffeic Acids; Dinoprostone; Endothelin Receptor Antagonists; Endothelins; Female; Intraocular Pressure; Male; Oleanolic Acid; Rabbits | 1995 |
Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist, 97-139.
Topics: Albumins; Animals; Binding Sites; Blood; Caffeic Acids; Calcium; Cells, Cultured; Decerebrate State; DNA; Endothelin Receptor Antagonists; Endothelins; Humans; In Vitro Techniques; Male; Molecular Structure; Oleanolic Acid; Peptides, Cyclic; Rats; Rats, Wistar | 1994 |
Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB209670, and 97-139.
Topics: Bosentan; Caffeic Acids; Endothelin Receptor Antagonists; Humans; Indans; Oleanolic Acid; Pulmonary Artery; Receptors, Endothelin; Sulfonamides | 1995 |
Effects of endothelin A and B receptors on aqueous humor dynamics in the rabbit eye.
Topics: Animals; Aqueous Humor; Caffeic Acids; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Female; Intraocular Pressure; Male; Oleanolic Acid; Rabbits; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Time Factors; Vasoconstrictor Agents; Viper Venoms | 1996 |
The effects of ETB receptor-selective agonist on IOP and blood-aqueous barrier in rabbit eyes: role of cyclooxygenase products.
Topics: Animals; Aqueous Humor; Blood-Aqueous Barrier; Caffeic Acids; Cyclooxygenase Inhibitors; Dinoprostone; Endothelin-1; Eye Proteins; Female; Indomethacin; Intraocular Pressure; Male; Oleanolic Acid; Prostaglandin-Endoperoxide Synthases; Rabbits; Receptors, Endothelin; Vasoconstrictor Agents; Viper Venoms | 1995 |
[Anterior chamber inflammation after the injection of endothelin-1 into the vitreous and the effect of ETA receptor antagonist].
Topics: Animals; Anterior Chamber; Aqueous Humor; Caffeic Acids; Dinoprostone; Endothelin Receptor Antagonists; Endothelin-1; Female; Inflammation; Leukotriene B4; Male; Oleanolic Acid; Rabbits; Receptor, Endothelin A; Receptors, Endothelin; Vitreous Body | 1997 |
Binding characterization of [3H]S-0139, an antagonist of the endothelin ET(A) receptor subtype.
Topics: Animals; Aorta, Thoracic; Caffeic Acids; Calcium; Cytosol; Endothelin Receptor Antagonists; Endothelins; In Vitro Techniques; Iodine Radioisotopes; Muscle, Smooth, Vascular; Oleanolic Acid; Swine; Triterpenes | 1998 |
Profiles of an intravenously available endothelin A-receptor antagonist, S-0139, for preventing cerebral vasospasm in a canine two-hemorrhage model.
Topics: Animals; Basilar Artery; Caffeic Acids; Disease Models, Animal; Dogs; Endothelin Receptor Antagonists; Female; Infusions, Intravenous; Ischemic Attack, Transient; Male; Oleanolic Acid; Spine; Subarachnoid Hemorrhage | 1998 |
Effects of endothelin receptor antagonists on anterior chamber inflammation induced by intravitreal injection of endothelin-1.
Topics: Animals; Caffeic Acids; Dinoprostone; Endothelin Receptor Antagonists; Endothelin-1; Eye Proteins; Female; Leukotriene B4; Male; Oleanolic Acid; Oligopeptides; Piperidines; Rabbits; Receptors, Endothelin; Uveitis, Anterior | 1999 |
Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats.
Topics: Animals; Caffeic Acids; Creatine; Down-Regulation; Endothelin Receptor Antagonists; Endothelins; Kidney; Kidney Failure, Chronic; Male; Nephrectomy; Oleanolic Acid; Protein Precursors; Proteinuria; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; RNA, Messenger; Sulfonamides | 1999 |
A preventive effect of a selective endothelin-A receptor antagonist, S-0139, on the erythropoietin-induced reduction of the renal cortical blood flow.
Topics: Animals; Caffeic Acids; Endothelin Receptor Antagonists; Erythropoietin; Humans; Kidney Cortex; Male; Oleanolic Acid; Rats; Rats, Wistar; Receptor, Endothelin A; Recombinant Proteins; Regional Blood Flow | 1999 |
Contribution of endothelin-1 to disruption of blood-brain barrier permeability in dogs.
Topics: Analysis of Variance; Animals; Blood; Blood-Brain Barrier; Caffeic Acids; Cell Membrane Permeability; Cisterna Magna; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Female; Fluorescein; Injections, Intraventricular; Male; Oleanolic Acid; Receptor, Endothelin A; Subarachnoid Hemorrhage | 1999 |
Therapy with the nonpeptide endothelin receptor antagonist 97-139 in a murine model of congestive heart failure: reduction of cardiac mass and myofiber hypertrophy.
Topics: Animals; Caffeic Acids; Cardiomegaly; Endothelin Receptor Antagonists; Female; Heart Failure; Mice; Mice, Inbred DBA; Myocardium; Oleanolic Acid; Organ Size | 2000 |
Endothelin receptor subtype antagonist activity of S-0139 in various isolated rabbit and canine arteries.
Topics: Animals; Arteries; Caffeic Acids; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelium, Vascular; In Vitro Techniques; Isometric Contraction; Male; Muscle, Smooth, Vascular; Oleanolic Acid; Rabbits; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Vasoconstrictor Agents; Viper Venoms | 2000 |
Endothelin-1 has a unique oxygen-saving effect by increasing contractile efficiency in the isolated rat heart.
Topics: Amiloride; Animals; Antihypertensive Agents; Caffeic Acids; Cardiotonic Agents; Drug Interactions; Endothelin-1; Heart; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Oleanolic Acid; Oligopeptides; Oxygen; Perfusion; Piperidines; Rats; Rats, Sprague-Dawley | 2001 |
Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Chemistry; Brain Edema; Caffeic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neuroprotective Agents; Oleanolic Acid; Peroxidase; Rats; Rats, Wistar; Receptor, Endothelin A; Reperfusion Injury; Survival Rate; Time Factors; Water | 2001 |
Synergistic effect of an endothelin type A receptor antagonist, S-0139, with rtPA on the neuroprotection after embolic stroke.
Topics: Animals; Blood Platelets; Blood-Brain Barrier; Brain; Caffeic Acids; Collagen Type IV; Drug Synergism; Endothelin Receptor Antagonists; Fibrinolytic Agents; Immunohistochemistry; Infarction, Middle Cerebral Artery; Intercellular Adhesion Molecule-1; Male; Neuroprotective Agents; Oleanolic Acid; Rats; Rats, Wistar; Receptor, PAR-1; Recovery of Function; Tight Junctions; Tissue Plasminogen Activator | 2008 |
Drug code names and other ethics-related matters.
Topics: Biomedical Research; Caffeic Acids; Drug Labeling; Endothelin A Receptor Antagonists; Forearm; Humans; Informed Consent; Oleanolic Acid; Patient Education as Topic | 2010 |
Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET) antagonist, in the human forearm blood flow model.
Topics: Adolescent; Adult; Blood Pressure; Caffeic Acids; Double-Blind Method; Endothelin A Receptor Antagonists; Endothelin-1; Forearm; Humans; Infusions, Intravenous; Male; Middle Aged; Oleanolic Acid; Plethysmography; Single-Blind Method; Vasoconstriction; Vasoconstrictor Agents; Young Adult | 2010 |